USD 0.79
(-19.94%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -3.97 Million USD | 39.7% |
2022 | -1.84 Million USD | 35.65% |
2021 | -3.73 Million USD | 35.67% |
2020 | -5.81 Million USD | 50.23% |
2019 | -11.24 Million USD | -252.56% |
2018 | -3.58 Million USD | -0.78% |
2017 | -3.09 Million USD | 27.21% |
2016 | -4.51 Million USD | -1068.11% |
2015 | -386.46 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -178.45 Thousand USD | 93.09% |
2024 Q2 | -307.14 Thousand USD | -72.11% |
2023 Q4 | -44.8 Thousand USD | 94.78% |
2023 Q3 | -857.98 Thousand USD | -477.91% |
2023 Q2 | -148.46 Thousand USD | 62.87% |
2023 Q1 | -399.89 Thousand USD | -55.01% |
2022 Q4 | -257.97 Thousand USD | 52.15% |
2022 Q2 | -563.36 Thousand USD | 37.8% |
2022 FY | - USD | 35.65% |
2022 Q1 | -905.73 Thousand USD | -5.7% |
2022 Q3 | -539.11 Thousand USD | 4.3% |
2021 Q2 | -1.24 Million USD | -83.63% |
2021 Q3 | -960.45 Thousand USD | 22.77% |
2021 Q4 | -856.91 Thousand USD | 10.78% |
2021 FY | - USD | 35.67% |
2021 Q1 | -677.26 Thousand USD | -145.03% |
2020 Q2 | -2.83 Million USD | -149.34% |
2020 FY | - USD | 50.23% |
2020 Q4 | 1.5 Million USD | 145.04% |
2020 Q3 | -3.33 Million USD | -17.7% |
2020 Q1 | -1.13 Million USD | 53.56% |
2019 Q4 | -2.45 Million USD | -290.3% |
2019 FY | - USD | -252.56% |
2019 Q1 | -5.87 Million USD | -615.4% |
2019 Q2 | -2.29 Million USD | 61.04% |
2019 Q3 | -627.76 Thousand USD | 72.59% |
2018 Q4 | -821.81 Thousand USD | 9.63% |
2018 FY | - USD | -0.78% |
2018 Q1 | 937.41 Thousand USD | 170.68% |
2018 Q2 | 517.76 Thousand USD | -44.77% |
2018 Q3 | -909.41 Thousand USD | -275.64% |
2017 Q3 | -1.69 Million USD | 1.73% |
2017 Q4 | -1.32 Million USD | 21.76% |
2017 Q2 | -1.72 Million USD | 5.7% |
2017 FY | - USD | 27.21% |
2017 Q1 | -1.82 Million USD | 55.3% |
2016 Q4 | -4.09 Million USD | -587.31% |
2016 FY | - USD | -1068.11% |
2016 Q3 | -595.41 Thousand USD | -455.14% |
2016 Q1 | -116.68 Thousand USD | 0.0% |
2016 Q2 | -107.25 Thousand USD | 8.08% |
2015 FY | - USD | 0.0% |
2015 Q2 | -51.38 Thousand USD | 0.0% |
2015 Q3 | -76.48 Thousand USD | -48.86% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Ontrak, Inc. | -14.41 Million USD | 72.429% |
iCoreConnect Inc. | -11.87 Million USD | 66.541% |
Augmedix, Inc. | -17.68 Million USD | 77.52% |
BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 101.137% |
CareCloud, Inc. | -31.29 Million USD | 87.297% |
CareCloud, Inc. | -31.29 Million USD | 87.297% |
HealthEquity, Inc. | 282.41 Million USD | 101.407% |
Inovalon Holdings, Inc. | 186.56 Million USD | 102.13% |
Nutex Health, Inc. | -14.58 Million USD | 72.741% |
OneMedNet Corporation | -11.97 Million USD | 66.797% |
Progyny, Inc. | 64.46 Million USD | 106.166% |
Omnicell, Inc. | 60.69 Million USD | 106.549% |
Renalytix Plc | -28.52 Million USD | 86.064% |
Schrödinger, Inc. | -171.89 Million USD | 97.688% |
Simulations Plus, Inc. | 6.13 Million USD | 164.829% |
SOPHiA GENETICS SA | -70.7 Million USD | 94.378% |
Streamline Health Solutions, Inc. | -12.81 Million USD | 68.986% |
Minerva Surgical, Inc. | -20.07 Million USD | 80.199% |
GE HealthCare Technologies Inc. | 3.56 Billion USD | 100.112% |
Sharecare, Inc. | -67.25 Million USD | 94.09% |
Aclarion, Inc. | -4.14 Million USD | 4.002% |
CareMax, Inc. | -590.46 Million USD | 99.327% |
Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | 24.651% |
Forian Inc. | 2.75 Million USD | 244.519% |
Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | 24.651% |
HeartBeam, Inc. | 675 Thousand USD | 688.844% |
GeneDx Holdings Corp. | -136.46 Million USD | 97.087% |
Definitive Healthcare Corp. | -241.22 Million USD | 98.352% |
10x Genomics, Inc. | -205.11 Million USD | 98.062% |
Zhongchao Inc. | -4.9 Million USD | 18.923% |
Accolade, Inc. | -71.19 Million USD | 94.417% |
MSP Recovery, Inc. | -69.22 Million USD | 94.258% |
R1 RCM Inc. | 426.2 Million USD | 100.933% |
Spok Holdings, Inc. | 26.29 Million USD | 115.115% |
Privia Health Group, Inc. | 27.18 Million USD | 114.623% |
EUDA Health Holdings Limited | -8.3 Million USD | 52.114% |
TruBridge, Inc. | -15.39 Million USD | 74.175% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 101.137% |
Sharecare, Inc. | -67.25 Million USD | 94.09% |
Health Catalyst, Inc. | -66.46 Million USD | 94.02% |
GoodRx Holdings, Inc. | 108.82 Million USD | 103.652% |
Premier, Inc. | 286.08 Million USD | 101.389% |
HealthStream, Inc. | 59.58 Million USD | 106.67% |
Certara, Inc. | 23.84 Million USD | 116.67% |
GeneDx Holdings Corp. | -136.46 Million USD | 97.087% |
Ontrak, Inc. | -14.41 Million USD | 72.429% |
SHL Telemedicine Ltd. | 3.28 Million USD | 221.05% |
CareCloud, Inc. | -31.29 Million USD | 87.297% |
EUDA Health Holdings Limited | -8.3 Million USD | 52.114% |
HeartBeam, Inc. | 675 Thousand USD | 688.844% |
Mangoceuticals, Inc. | -9.18 Million USD | 56.738% |
CareMax, Inc. | -590.46 Million USD | 99.327% |
Healthcare Triangle, Inc. | -4.1 Million USD | 3.151% |
National Research Corporation | 45.98 Million USD | 108.643% |
Aclarion, Inc. | -4.14 Million USD | 4.002% |
OptimizeRx Corporation | -21.3 Million USD | 81.347% |